Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 3 - Drugs for disorders of the metabolism
Patents for A61P 3 - Drugs for disorders of the metabolism (129,789)
11/2000
11/07/2000US6143910 Methods for preparation and use of 1α, 24(S) -dihydroxy vitamin D2
11/07/2000US6143894 Preparation of [1S-[1A,2B,3B,4A(S*)]]-4-[7-[[1-(3-chloro-2-thienyl)methyl propyl]amino] -3H-imidazo[4,5-B]pyridin-3-yl]-N-ethyl-2,3-dihydroxycyclopentanecarboxa mide
11/07/2000US6143787 Heterocyclic or aromatic oxoacids
11/07/2000US6143770 Mixtures of tocotrienol and nicotinic acid
11/07/2000US6143757 Chemical compounds
11/07/2000US6143728 Guanylhydrazones useful for treating diseases associated with T cell activation
11/07/2000US6143718 Treatment of Type II diabetes mellutis with amylin agonists
11/07/2000US6143521 Human bombesin receptor subtype-3sb
11/07/2000US6143326 Therapy for osteoporosis
11/07/2000US6143323 Containing n-(4-isopropylcyclohexanecarbonyl)phenylalanine inhydroxypropyl cellulose
11/07/2000US6143306 Methods for treating pancreatic disorders
11/07/2000US6143295 Low molecular weight protein
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/02/2000WO2000065346A1 Diagnosis of human kidney diseases
11/02/2000WO2000065069A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000WO2000065068A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000WO2000065054A2 Human membrane-associated proteins
11/02/2000WO2000065028A2 TGF-α POLYPEPTIDES, FUNCTIONAL FRAGMENTS AND METHODS OF USE THEREFOR
11/02/2000WO2000065027A2 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000WO2000064940A1 Insulin crystals for pulmonary administration
11/02/2000WO2000064931A1 A ligand of the protein 'beacon'
11/02/2000WO2000064921A2 Process of purifying phytosterols from wood or plant-derived sources by means of metal salt complexes and compositions resulting therefrom
11/02/2000WO2000064911A1 Ligands for metabotropic glutamate receptors
11/02/2000WO2000064899A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/02/2000WO2000064896A1 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
11/02/2000WO2000064894A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000WO2000064893A2 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000WO2000064892A2 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000WO2000064888A1 Di-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064884A1 Piperidyl-imidazole derivatives, their preparations and therapeutic uses
11/02/2000WO2000064880A1 Selective npy (y5) antagonists
11/02/2000WO2000064878A1 Cyclo-alkyl substituted benzimidazoles and their use as parp inhibitors
11/02/2000WO2000064876A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000WO2000064854A1 Conjugated fatty acid esters
11/02/2000WO2000064485A2 Specifically targeted catalytic antagonists and uses thereof
11/02/2000WO2000064454A2 Pharmaceutical composition comprising an inositol and a metal ion for improving insulin sensitivity and glucose metabolism
11/02/2000WO2000064445A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/02/2000WO2000064443A1 Synergistic effects of amlodipine and atorvastatin
11/02/2000WO2000064441A2 Compound for use as a medicament for treatment of disorders involving bronchocontraction
11/02/2000WO2000064438A1 Cardiovascular and bone treatment using isoflavones
11/02/2000WO2000064436A1 Methods of delivery of cetyl myristoleate
11/02/2000WO2000064426A2 Carnitine and inositol phosphate-containing composition useful as dietary supplement or drug
11/02/2000WO2000064420A2 Compositions and methods for treating amyloidosis using sulphonate derivatives
11/02/2000WO2000064279A1 Cactus fruit health products
11/02/2000WO2000064278A1 Ginseng berry health products
11/02/2000WO2000064273A1 Complete feed for fish larvae and method for preparing same
11/02/2000WO2000041528A3 Improved controlled release compositions and method
11/02/2000WO2000040714A3 Therapeutic phosphodiesterase inhibitors
11/02/2000WO2000040584A3 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents
11/02/2000WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
11/02/2000WO2000039083A3 Pyrazole compounds and uses thereof
11/02/2000WO2000037469B1 Process for preparing n6-substituted deaza-adenosine derivatives
11/02/2000WO2000030622A3 Utilisation of dialkylfumarates for treating host-versus-graft reactions and auto-immune diseases
11/02/2000WO1999063973A3 PHARMACEUTICAL COMPOSITIONS AND USES FOR ANDROST-5-ENE-3β,17β-DIOL
11/02/2000EP1048668A2 Process for preparing spray granules containing riboflavin
11/02/2000EP1048295A2 Pharmaceutical compositions comprising co-micronized fenofibrate
11/02/2000EP1047792A1 A method for depopulating of vertebrate testis and for generation of transgenic species
11/02/2000EP1047712A1 Fatty acid synthase mrna binding protein
11/02/2000EP1047675A1 Chemokine receptor antagonists and methods of use therefor
11/02/2000EP1047673A1 Novel heterocyclic compounds
11/02/2000EP1047668A1 Triazepinones, process for their preparation and their therapeutic application
11/02/2000EP1047437A1 Sea cucumber carotenoid lipid fraction products and methods of use
11/02/2000EP1047434A2 Use of glycosaminoglycans for producing pharmaceutical preparations for treating diabetes-associated diseases of the eye
11/02/2000EP1047428A1 Pharmaceutically active morpholinol
11/02/2000EP1047421A2 Inhibition of lipoprotein oxidation
11/02/2000DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk
11/02/2000CA2377135A1 Dsp-10 dual-specificity map kinsase phosphatase
11/02/2000CA2372154A1 Process of purifying phytosterols from wood or plant-derived sources and compositions resulting therefrom
11/02/2000CA2371308A1 Tri-aryl acid derivatives as ppar receptor ligands
11/02/2000CA2371274A1 Selective npy (y5) antagonists
11/02/2000CA2371242A1 Diagnosis of human kidney diseases
11/02/2000CA2371241A1 Tgf-.alpha. polypeptides, functional fragments and methods of use therefor
11/02/2000CA2371064A1 Methods of delivery of cetyl myristoleate
11/02/2000CA2371055A1 Compositions and methods for improving insulin sensitivity and glucose metabolism in mammals
11/02/2000CA2370639A1 Synergistic effects of amlodipine and atorvastatin metabolite as a basis for combination therapy
11/02/2000CA2370607A1 Bicyclic acyl guanidine sodium/proton exchange inhibitors and method
11/02/2000CA2370553A1 Cardiovascular and bone treatment using isoflavones
11/02/2000CA2370547A1 Dsp-5 dual-specificity map kinase phosphatase
11/02/2000CA2370302A1 Insulin crystals for pulmonary administration
11/02/2000CA2370286A1 A ligand of the protein "beacon"
11/02/2000CA2370280A1 Polymorph of 5-[4-[2- (n-methyl-n-( 2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt
11/02/2000CA2370264A1 5-pyridyl-1,3-azole compounds, process for producing the same and use thereof
11/02/2000CA2370262A1 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000CA2370258A1 Thiazolidinedione derivative and its use as antidiabetic
11/02/2000CA2370195A1 Human membrane-associated proteins
11/02/2000CA2368213A1 Specifically targeted catalytic antagonists and uses thereof
11/02/2000CA2367980A1 Complete feed for fish larvae and method for preparing same
11/02/2000CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same
11/02/2000CA2367682A1 Tetracyclic azepinoindole compounds as 5-ht receptor ligands
11/01/2000CN1272109A Process for producing isooxazolidinedione compound
11/01/2000CN1271734A Substituted 19-norsteroid, its preparation and intermediate and its medical use and composition
11/01/2000CN1271592A Health-care oil for reducing cholesterol and its preparing process
11/01/2000CN1271577A Medicine preparation and its use and the use of high grade primary alcohol mixture
11/01/2000CN1058019C 环状氨基酸衍生物 Cyclic amino acid derivatives
10/2000
10/31/2000US6140512 Process for the production of lipoic acid
10/31/2000US6140474 Monoclonal antibody reactive with human-origin CETP and method of quantifying human-origin CETP
10/31/2000US6140354 N-substituted aminotetralins as ligands for the neuropeptide Y Y5 receptor useful in the treatment of obesity and other disorders
10/31/2000US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists
10/31/2000US6140343 Cholesteryl ester transfer protein inhibitors which are used to elevate highdensity lipoprotein-cholesterol and to lower low density lipoprotein-cholesterol and triglycerides; for treating atherosclerosis, peripheral vascular disease, obesity
1 ... 1088 1089 1090 1091 1092 1093 1094 1095 1096 1097 1098 1099 1100 1101 1102 1103 1104 1105 1106 1107 1108 ... 1298